Insider Trading April 7, 2026

Mentor Capital CEO Makes Small Purchase as Stock Falls; Auditor Switch Confirmed

Chester Billingsley buys 897 shares amid recent slide; Mentor Capital names Cherry Bekaert as new auditor after acquisition of prior firm

By Hana Yamamoto MNTR
Mentor Capital CEO Makes Small Purchase as Stock Falls; Auditor Switch Confirmed
MNTR

Mentor Capital CEO Chester Billingsley reported a purchase of 897 common shares at $0.063 per share on April 7, 2026, a transaction valued at approximately $56. The acquisition follows a sharp one-week decline in the stock and a recent conversion of Series Q preferred shares into common shares. Separately, Mentor Capital disclosed a change in its independent registered public accounting firm to Cherry Bekaert LLP effective January 13, following Cherry Bekaert's acquisition of the company's former auditor.

Key Points

  • CEO Chester Billingsley purchased 897 common shares at $0.063 per share on April 7, 2026, a transaction worth about $56.
  • Billingsley converted 11 Series Q Preferred Shares into 5,906,107 common shares on April 3, 2026, as reported in SEC filings.
  • Mentor Capital appointed Cherry Bekaert LLP as its new independent registered public accounting firm, effective January 13, following Cherry Bekaert's acquisition of the prior auditor; the audit committee and board approved the engagement.

Mentor Capital (NASDAQ: MNTR) reported an insider purchase this month as Chief Executive Officer Chester Billingsley acquired 897 shares of common stock at $0.063 per share, a transaction whose total value was approximately $56. The purchase, recorded on a Form 4 filed with the Securities and Exchange Commission, occurred on April 7, 2026. At the time of reporting the stock had declined 24.6% over the prior week and was trading at $0.06.

In filings disclosed earlier in the month, Billingsley converted 11 shares of Series Q Preferred Shares into 5,906,107 shares of common stock on April 3, 2026. That conversion and the subsequent Form 4 reporting provide contemporaneous documentation of recent insider activity and share-class movement within the company.

An InvestingPro analysis referenced in company disclosures indicates that the stock remains undervalued at current price levels and notes the availability of 11 additional ProTips for subscribers. The filing-based summary cited InvestingPro as the source of that valuation perspective.


In a separate disclosure related to corporate reporting, Mentor Capital announced the appointment of Cherry Bekaert LLP as its new independent registered public accounting firm. The change became effective January 13 and was disclosed in a statement based on a recent SEC filing. The transition followed Cherry Bekaert's acquisition of Mentor Capital's prior auditor, Spicer Jeffries LLP. Mentor Capital's audit committee and board of directors approved the engagement of Cherry Bekaert.

The audit firm change marks an official update to the company's auditing arrangement after the acquisition of its previous auditor by Cherry Bekaert. The company disclosed the timeline and approvals in the SEC-filed statement.


Below are the principal facts summarized from the filings and company statements:

  • Insider purchase: Chester Billingsley bought 897 shares at $0.063 per share on April 7, 2026; transaction value approximately $56.
  • Share conversion: On April 3, 2026, 11 Series Q Preferred Shares were converted into 5,906,107 common shares.
  • Auditor change: Cherry Bekaert LLP engaged as independent registered public accounting firm, effective January 13, following its acquisition of Spicer Jeffries LLP; engagement approved by the audit committee and board.
  • Market context: The company stock had fallen 24.6% over the prior week and was trading at $0.06 at the time of reporting; InvestingPro analysis cited the stock as undervalued and referenced 11 additional ProTips.

The disclosures are drawn from SEC filings and statements by the company as cited in the filings. The documents outline the timing and mechanics of the insider transaction, the preferred-share conversion, and the change in the company's independent auditor.

Risks

  • Share-count change from the April 3 conversion introduces potential dilution and alters the company’s outstanding common share profile - impacts equity holders and small-cap market participants.
  • The stock experienced a 24.6% decline in the prior week and was trading at $0.06, indicating recent price volatility that could affect investor sentiment in small-cap equities.
  • The change in independent auditor following the acquisition of the prior auditor may create transitional audit and reporting uncertainties until the new engagement is fully operational - relevant to corporate governance and accounting oversight.

More from Insider Trading

Vir Biotechnology CEO Executes $664K Sale Under 10b5-1 Plan; Company Raises $172.5M in Offering Apr 7, 2026 United Therapeutics CFO Disposes $5.58M in Stock, Exercises Options for 10,000 Shares Apr 7, 2026 Alnylam CHRO Sells $1.27 Million in Stock; Keeps 9,443 Shares Apr 7, 2026 Oscar Health CEO Executes Large Share Transactions as Stock Climbs 11% Apr 7, 2026 AH Realty Trust Director Increases Stake with $5,747 in Purchases Apr 7, 2026